Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a…
By: Wilson Sonsini Goodrich & Rosati
SOURCE: Personal Injury & Products Liability RSS Feed | JD Supra Law News – Read entire story here.